Drug · DIN 02485672
AG-DUTASTERIDE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 19, 2025; first marketed August 19, 2025.
- Drug Identification Number (DIN)
- 02485672
- Company (DIN owner)
- Angita Pharma Inc.Boucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Dutasteride G04CB02
- Class
- Human
- Record last updated
- August 21, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DUTASTERIDE | 0.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 24, 2024: NOC 33298Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Manufacturers
- February 12, 2019: NOC 21849Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Companies